Bajaj Healthcare Limited (BAJAJHCARE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bajaj Healthcare Limited (BAJAJHCARE) has a cash flow conversion efficiency ratio of 0.103x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs501.85 Million ≈ $5.43 Million USD) by net assets (Rs4.86 Billion ≈ $52.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Bajaj Healthcare Limited (BAJAJHCARE) total market value for the company's overall valuation and market capitalisation.
Bajaj Healthcare Limited - Cash Flow Conversion Efficiency Trend (2011–2026)
This chart illustrates how Bajaj Healthcare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Bajaj Healthcare Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bajaj Healthcare Limited ranked by their cash flow conversion efficiency. Explore cash flow quality index of Bajaj Healthcare Limited to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Reyon Pharmaceutical Co Ltd
KO:102460
|
-0.007x |
|
Quanterix Corp
NASDAQ:QTRX
|
0.011x |
|
It's Skin Co Ltd
KO:226320
|
0.010x |
|
SaltX Technology Holding AB
ST:SALT-B
|
-0.078x |
|
Aroa Biosurgery Ltd
AU:ARX
|
0.045x |
|
Dong Phu Rubber JSC
VN:DPR
|
0.036x |
|
Synalloy Corporation
NASDAQ:ACNT
|
-0.066x |
|
Norstar
TA:NSTR
|
0.024x |
Annual Cash Flow Conversion Efficiency for Bajaj Healthcare Limited (2011–2026)
The table below shows the annual cash flow conversion efficiency of Bajaj Healthcare Limited from 2011 to 2026. View BAJAJHCARE share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs5.33 Billion ≈ $57.64 Million |
Rs372.23 Million ≈ $4.03 Million |
0.070x | +663.44% |
| 2025-03-31 | Rs4.66 Billion ≈ $50.41 Million |
Rs-57.78 Million ≈ $-624.87K |
-0.012x | -103.74% |
| 2024-03-31 | Rs2.78 Billion ≈ $30.10 Million |
Rs922.94 Million ≈ $9.98 Million |
0.332x | +646.11% |
| 2023-03-31 | Rs3.68 Billion ≈ $39.76 Million |
Rs-223.24 Million ≈ $-2.41 Million |
-0.061x | -3007.22% |
| 2022-03-31 | Rs3.28 Billion ≈ $35.52 Million |
Rs6.86 Million ≈ $74.19K |
0.002x | -98.76% |
| 2021-03-31 | Rs2.58 Billion ≈ $27.95 Million |
Rs435.58 Million ≈ $4.71 Million |
0.169x | +24.21% |
| 2020-03-31 | Rs1.52 Billion ≈ $16.40 Million |
Rs205.75 Million ≈ $2.23 Million |
0.136x | -30.38% |
| 2019-03-31 | Rs1.29 Billion ≈ $13.96 Million |
Rs251.69 Million ≈ $2.72 Million |
0.195x | +33.31% |
| 2018-03-31 | Rs1.14 Billion ≈ $12.29 Million |
Rs166.14 Million ≈ $1.80 Million |
0.146x | -37.16% |
| 2017-03-31 | Rs990.00 Million ≈ $10.71 Million |
Rs230.39 Million ≈ $2.49 Million |
0.233x | -17.95% |
| 2016-03-31 | Rs886.32 Million ≈ $9.59 Million |
Rs251.38 Million ≈ $2.72 Million |
0.284x | -60.35% |
| 2015-03-31 | Rs390.72 Million ≈ $4.23 Million |
Rs279.51 Million ≈ $3.02 Million |
0.715x | +29.24% |
| 2014-03-31 | Rs315.57 Million ≈ $3.41 Million |
Rs174.68 Million ≈ $1.89 Million |
0.554x | +12.94% |
| 2013-03-31 | Rs295.85 Million ≈ $3.20 Million |
Rs145.00 Million ≈ $1.57 Million |
0.490x | +74.79% |
| 2012-03-31 | Rs306.41 Million ≈ $3.31 Million |
Rs85.92 Million ≈ $929.15K |
0.280x | +86.89% |
| 2011-03-31 | Rs299.91 Million ≈ $3.24 Million |
Rs44.99 Million ≈ $486.60K |
0.150x | -- |
About Bajaj Healthcare Limited
Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, … Read more